Non-Targeted Metabolomics Analysis of the Effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Muscle, Liver and Serum Metabolism In Vivo

Background: More than 90 tyrosine kinases have been implicated in the pathogenesis of malignant transformation and tumor angiogenesis. Tyrosine kinase inhibitors (TKIs) have emerged as effective therapies in treating cancer by exploiting this kinase dependency. The TKI erlotinib targets the epiderma...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Metabolites
Main Authors: Jensen, Brian C., Parry, Traci L., Huang, Wei, Ilaiwy, Amro, Bain, James R., Muehlbauer, Michael J., O’Neal, Sara K., Patterson, Cam, Johnson, Gary L., Willis, Monte S.
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2017
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5618316/
https://ncbi.nlm.nih.gov/pubmed/28640223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo7030031
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker